Injuries and treatment in the oropharynx associated with sars-cov-2

Descripción del Articulo

   COVID-19 is a communicable disease caused by severe acute respiratory syndrome (SARS-COV-2). The oral cavity is a route of entry for SARS-COV-2. Oral epithelial cells, taste buds, and glands play an important role as they express cellular entry factors for SARS-COV-2, such as angiotensin-converti...

Descripción completa

Detalles Bibliográficos
Autores: Li-Pereyra, Carmen Del Pilar, Girano Castaños, Jorge Alberto, Vergara Pérez, Moraima Raquel, Iveros Oré, Lorena, Manrique Cabana, Ivonne, Guizado de la Cruz, Melissa, Dongo Pandal, Solange
Formato: artículo
Fecha de Publicación:2022
Institución:Universidad de San Martín de Porres
Repositorio:Revistas - Universidad de San Martín de Porres
Lenguaje:español
OAI Identifier:oai:revistas.usmp.edu.pe:article/2467
Enlace del recurso:https://portalrevistas.aulavirtualusmp.pe/index.php/Rev-Kiru0/article/view/2467
Nivel de acceso:acceso abierto
Materia:Oropharyngeal injuries
sars-cov-2
mouthwashes
Lesiones orofaríngeas
enjuagues bucales
id REVUSMP_6b898388e595cf2c3bec98cb4daec7f3
oai_identifier_str oai:revistas.usmp.edu.pe:article/2467
network_acronym_str REVUSMP
network_name_str Revistas - Universidad de San Martín de Porres
repository_id_str
dc.title.none.fl_str_mv Injuries and treatment in the oropharynx associated with sars-cov-2
Lesiones y tratamiento en orofaringe asociadas al sars-cov-2
title Injuries and treatment in the oropharynx associated with sars-cov-2
spellingShingle Injuries and treatment in the oropharynx associated with sars-cov-2
Li-Pereyra, Carmen Del Pilar
Oropharyngeal injuries
sars-cov-2
mouthwashes
Lesiones orofaríngeas
sars-cov-2
enjuagues bucales
title_short Injuries and treatment in the oropharynx associated with sars-cov-2
title_full Injuries and treatment in the oropharynx associated with sars-cov-2
title_fullStr Injuries and treatment in the oropharynx associated with sars-cov-2
title_full_unstemmed Injuries and treatment in the oropharynx associated with sars-cov-2
title_sort Injuries and treatment in the oropharynx associated with sars-cov-2
dc.creator.none.fl_str_mv Li-Pereyra, Carmen Del Pilar
Girano Castaños, Jorge Alberto
Vergara Pérez, Moraima Raquel
Iveros Oré, Lorena
Manrique Cabana, Ivonne
Guizado de la Cruz, Melissa
Dongo Pandal, Solange
author Li-Pereyra, Carmen Del Pilar
author_facet Li-Pereyra, Carmen Del Pilar
Girano Castaños, Jorge Alberto
Vergara Pérez, Moraima Raquel
Iveros Oré, Lorena
Manrique Cabana, Ivonne
Guizado de la Cruz, Melissa
Dongo Pandal, Solange
author_role author
author2 Girano Castaños, Jorge Alberto
Vergara Pérez, Moraima Raquel
Iveros Oré, Lorena
Manrique Cabana, Ivonne
Guizado de la Cruz, Melissa
Dongo Pandal, Solange
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv Oropharyngeal injuries
sars-cov-2
mouthwashes
Lesiones orofaríngeas
sars-cov-2
enjuagues bucales
topic Oropharyngeal injuries
sars-cov-2
mouthwashes
Lesiones orofaríngeas
sars-cov-2
enjuagues bucales
description    COVID-19 is a communicable disease caused by severe acute respiratory syndrome (SARS-COV-2). The oral cavity is a route of entry for SARS-COV-2. Oral epithelial cells, taste buds, and glands play an important role as they express cellular entry factors for SARS-COV-2, such as angiotensin-converting enzyme 2 (ACE2) and type 2 transmembrane serine protease (TMPRSS2).Oropharyngeal manifestations were found in the oral cavity, mainly in the tongue and hard palate. In mild cases, the use of alcohol-free mouthwash Chlorhexidine 0.12%, antibiotic therapy, and in severe cases photobiomodulation therapy was indicated, in other cases the lesions disappeared as the disease subsided.The virus can be detected in saliva, even before symptoms of COVID-19 appear. Reducing oral viral load could lead to a lower risk of transmission mainly through salivary droplets or aerosols. The use of mouthwashes is intended to reduce the bacterial load in infected patients who come to dental care. Among them we have chlorhexidine used in two concentrations of 0.12% and 0.2%. Both were found to be effective. Another of them is cetylpyridinium chloride, there is evidence that its use reduces viral load in patients with COVID-19 for up to six hours. Povidone iodine has also been shown to reduce viral load as a 0.23% mouthwash for 15 seconds prior to dental consultation. Another of the rinses used for this purpose is 1% hydrogen peroxide, since SARS-COV2 is vulnerable to oxidation.  
publishDate 2022
dc.date.none.fl_str_mv 2022-10-31
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://portalrevistas.aulavirtualusmp.pe/index.php/Rev-Kiru0/article/view/2467
url https://portalrevistas.aulavirtualusmp.pe/index.php/Rev-Kiru0/article/view/2467
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://portalrevistas.aulavirtualusmp.pe/index.php/Rev-Kiru0/article/view/2467/Lesiones%20y%20tratamiento%20en%20orofaringe%20asociadas%20al%20%20SARS-CoV-2
https://portalrevistas.aulavirtualusmp.pe/index.php/Rev-Kiru0/article/view/2467/Lesiones%20y%20tratamiento%20en%20orofaringe%20asociadas%20%20al%20SARS-CoV-2
dc.rights.none.fl_str_mv Derechos de autor 2022 Revista KIRU
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2022 Revista KIRU
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/xml
dc.publisher.none.fl_str_mv Universidad de San Martín de Porres, Facultad de Odontología.
publisher.none.fl_str_mv Universidad de San Martín de Porres, Facultad de Odontología.
dc.source.none.fl_str_mv KIRU ; Vol. 19 No. 1 (2022): KIRU (ENERO - MARZO)
KIRU ISSN (Impreso): 1812 - 7886 ISSN (Digital): 2410-2717; Vol. 19 Núm. 1 (2022): KIRU (ENERO - MARZO)
2410-2717
1812-7886
reponame:Revistas - Universidad de San Martín de Porres
instname:Universidad de San Martín de Porres
instacron:USMP
instname_str Universidad de San Martín de Porres
instacron_str USMP
institution USMP
reponame_str Revistas - Universidad de San Martín de Porres
collection Revistas - Universidad de San Martín de Porres
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1843712219545600000
spelling Injuries and treatment in the oropharynx associated with sars-cov-2Lesiones y tratamiento en orofaringe asociadas al sars-cov-2Li-Pereyra, Carmen Del PilarGirano Castaños, Jorge AlbertoVergara Pérez, Moraima RaquelIveros Oré, LorenaManrique Cabana, IvonneGuizado de la Cruz, MelissaDongo Pandal, SolangeOropharyngeal injuriessars-cov-2mouthwashesLesiones orofaríngeassars-cov-2enjuagues bucales   COVID-19 is a communicable disease caused by severe acute respiratory syndrome (SARS-COV-2). The oral cavity is a route of entry for SARS-COV-2. Oral epithelial cells, taste buds, and glands play an important role as they express cellular entry factors for SARS-COV-2, such as angiotensin-converting enzyme 2 (ACE2) and type 2 transmembrane serine protease (TMPRSS2).Oropharyngeal manifestations were found in the oral cavity, mainly in the tongue and hard palate. In mild cases, the use of alcohol-free mouthwash Chlorhexidine 0.12%, antibiotic therapy, and in severe cases photobiomodulation therapy was indicated, in other cases the lesions disappeared as the disease subsided.The virus can be detected in saliva, even before symptoms of COVID-19 appear. Reducing oral viral load could lead to a lower risk of transmission mainly through salivary droplets or aerosols. The use of mouthwashes is intended to reduce the bacterial load in infected patients who come to dental care. Among them we have chlorhexidine used in two concentrations of 0.12% and 0.2%. Both were found to be effective. Another of them is cetylpyridinium chloride, there is evidence that its use reduces viral load in patients with COVID-19 for up to six hours. Povidone iodine has also been shown to reduce viral load as a 0.23% mouthwash for 15 seconds prior to dental consultation. Another of the rinses used for this purpose is 1% hydrogen peroxide, since SARS-COV2 is vulnerable to oxidation.   El COVID-19 es una enfermedad transmisible provocado por el síndrome respiratorio agudo severo (SARS-COV-2). La cavidad oral es una ruta de entrada para el SARS-COV-2.  Las células de epitelio oral, papilas gustativas y glándulas tienen un rol importante ya que expresan factores de entrada celular para el SARS-COV-2, como la Enzima convertidora de angiotensina 2 (ACE2) y Serina proteasa transmembrana de tipo 2 (TMPRSS2).Se encontraron manifestaciones orofaríngeas en la cavidad oral,  principalmente en la lengua y paladar duro. En los casos leves se indicó el uso  de enjuagatorio bucal sin alcohol Clorhexidina 0.12%, antibioterapia, y en casos graves terapia de photobiomodulation, en otros casos las lesiones desaparecieron  a medida  que cedia la enfermedad.El virus puede detectarse en la saliva, incluso antes de que aparezcan los síntomas del COVID-19. La reducción de la carga viral oral podría conducir a un menor riesgo de transmisión principalmente a través de las gotitas salivales o aerosoles. El uso de enjuagues bucales tiene por finalidad disminuir la carga bacteriana en pacientes infectados que acuden a  la atención odontológica. Entre ellos tenemos a la clorhexidina utilizada  en dos concentraciones de 0,12% y 0,2% . Se encontró que  ambos son efectivos. Otro de ellos es el cloruro de cetilpiridinio ,hay evidencia que su uso reduce la carga viral  en pacientes con COVID-19 hasta por seis horas. La yodo povidona también ha demostrado reducir la carga viral como enjuague bucal al 0,23% durante 15 segundos previa a la consulta odontología. Otro de los enjuagues  utilizado para este fin , es el peróxido de hidrogeno al 1%, ya que el SARS-COV2 es vulnerable a la oxidaciones . Universidad de San Martín de Porres, Facultad de Odontología.2022-10-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://portalrevistas.aulavirtualusmp.pe/index.php/Rev-Kiru0/article/view/2467KIRU ; Vol. 19 No. 1 (2022): KIRU (ENERO - MARZO) KIRU ISSN (Impreso): 1812 - 7886 ISSN (Digital): 2410-2717; Vol. 19 Núm. 1 (2022): KIRU (ENERO - MARZO)2410-27171812-7886reponame:Revistas - Universidad de San Martín de Porresinstname:Universidad de San Martín de Porresinstacron:USMPspahttps://portalrevistas.aulavirtualusmp.pe/index.php/Rev-Kiru0/article/view/2467/Lesiones%20y%20tratamiento%20en%20orofaringe%20asociadas%20al%20%20SARS-CoV-2https://portalrevistas.aulavirtualusmp.pe/index.php/Rev-Kiru0/article/view/2467/Lesiones%20y%20tratamiento%20en%20orofaringe%20asociadas%20%20al%20SARS-CoV-2Derechos de autor 2022 Revista KIRUinfo:eu-repo/semantics/openAccessoai:revistas.usmp.edu.pe:article/24672023-10-06T00:20:40Z
score 12.780449
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).